世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バクテリオファージ抗菌薬の世界市場インサイト、2029年までの予測


Global Bacteriophages Antimicrobials Market Insights, Forecast to 2029

バクテリオファージは、単にファージと呼ばれることもあるが、細菌に感染し、その中で複製するウイルスである。バクテリオファージはバクテリアの天敵であり、その抗菌特性を利用することができる。バクテリオフ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年12月5日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

バクテリオファージは、単にファージと呼ばれることもあるが、細菌に感染し、その中で複製するウイルスである。バクテリオファージはバクテリアの天敵であり、その抗菌特性を利用することができる。バクテリオファージは細菌に特異的であり、ファージは通常、特定の菌株や細菌種にのみ感染する。

バクテリオファージは細菌の細胞表面にある特定のレセプターに付着することで細菌に感染する。いったん付着すると、ファージはその遺伝物質を細菌内に注入し、細菌の仕組みを乗っ取って複製し、新しいファージ粒子を作り出す。新しいファージ粒子が産生されると、最終的には細菌細胞を破裂または溶解させ、新しく形成されたファージを放出する。この結果、細菌細胞は破壊される。

バクテリオファージの重要な利点の一つは、その特異性である。ファージはそれぞれ宿主範囲が狭く、特定の種類や菌株にしか感染しない。この特異性により、ヒト細胞を含む非細菌細胞に影響を与えることなく、標的を絞った抗菌作用が可能になる。
バクテリオファージは、細菌感染に対する潜在的な治療薬として研究されてきた。ファージ療法として知られるこのアプローチでは、特定のファージを使って病原性細菌を標的にして死滅させる。ファージ療法は、抗生物質の代替療法あるいは補完療法として研究されている。バクテリオファージは、食品産業において細菌汚染を制御するために使用されている。バクテリオファージを食品に適用することで、有害な細菌を標的にしてその量を減らし、食品の安全性を向上させることができる。

世界のバクテリオファージ抗菌剤市場は、2023年には100万米ドルに達すると予想され、2022年の100万米ドルと比較すると、成長率は%である。川下産業からの需要の増加を背景に、バクテリオファージ抗菌剤産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは%である。

世界的に、バクテリオファージ抗菌薬の主要メーカーには、Vésale Bioscience、Adaptive Phage Therapeutics、Proteon Pharmaceuticals、PHIOGEN、Phageguard、Armata Pharmaceuticals、ACD Pharmaceuticals、SyntBioLab、Antibody Design Labsなどがあります。Vésale Bioscience社、Adaptive Phage Therapeutics社、Proteon Pharmaceuticals社が上位3社で、2022年の売上高シェアは合計で%でした。
消費地域を考慮すると、2022年のバクテリオファージ抗菌薬の販売量は、北米、欧州、アジア太平洋地域に占める割合が高い。アジア太平洋地域は、2023年から2029年までの年平均成長率(CAGR)が%で、2029年には販売シェアが%になり、急成長を遂げると推定される。さらに、中国はバクテリオファージ抗菌薬市場全体で重要な役割を担っており、業界関係者や投資家の注目を集めると推定される。

バクテリオファージ抗菌剤はヒト用、動物用、植物用などに分けられる。ヒト用は市場の主流製品であり、2022年の世界売上シェアは%で、2029年にはその割合は%になる。
バクテリオファージ抗菌剤は、医療、食品産業、農業、その他など様々な分野で広く使用されています。医療はバクテリオファージ抗菌剤産業の発展に最大のサポートを提供する。2022年、世界のバクテリオファージ抗菌薬の売上は、医療分野での売上が占め、その割合は2029年には%に達するだろう。

レポートの対象
本レポートは、2018年から2029年までの世界のバクテリオファージ抗菌薬市場の概要を紹介し、読者が世界のバクテリオファージ抗菌薬市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別の売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高および収益も強調しています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
プロテオン・ファーマシューティカルズ
フィオゲン
ファージガード
アルマタ製薬
ACDファーマシューティカルズ
シンバイオ研究所
抗体デザインラボ
APSバイオコントロール
バイオエックス
エコファージ
エコリセ
固定ファージ
イントラリティックス
ローカスバイオサイエンス
マイクレオス
オムニリティクス
タイプ別
エンドユーザー別
ヒト用
動物用
植物
ゲノム別
DsDNAバクテリオファージ
SsDNAバクテリオファージ
DsRNAバクテリオファージ
SsRNAバクテリオファージ
アプリケーション別
医療
食品産業
農業
その他
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章:製品の定義、種類、用途の紹介
第2章:2018年から2029年までの地域別収益および販売量分析
第3章:メーカーのバクテリオファージ抗菌薬の工場分布、バクテリオファージ抗菌薬の商業日、提供される製品タイプ、M&A、拡大活動を含む、メーカーの売上、収益、価格分析。
第4章:2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章:2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章:米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国&カナダにおける各国別製品売上高、収益分析
第7章:ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章:2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章:2018年から2029年までのアジア(中国を除く)における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア(中国を除く)各国の製品売上高、収益分析
第10章:2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章:メーカーの概要、企業の基本情報、主要事業、バクテリオファージ抗菌薬の紹介などをカバー。2018年から2023年までの各社のバクテリオファージ抗菌薬の売上高、収益、価格、およびグロスマージン
第12章:原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章:市場機会と課題分析
第14章:バクテリオファージ抗菌薬に関するQYResearchの結論
第15章 QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 Bacteriophages Antimicrobials Product Introduction
1.2 Market by Type
1.2.1 Global Bacteriophages Antimicrobials Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 for Human
1.2.3 for Animals
1.2.4 for Plants
1.3 Market by Application
1.3.1 Global Bacteriophages Antimicrobials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Food Industry
1.3.4 Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bacteriophages Antimicrobials Sales Estimates and Forecasts 2018-2029
2.2 Global Bacteriophages Antimicrobials Revenue by Region
2.2.1 Global Bacteriophages Antimicrobials Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bacteriophages Antimicrobials Revenue by Region (2018-2023)
2.2.3 Global Bacteriophages Antimicrobials Revenue by Region (2024-2029)
2.2.4 Global Bacteriophages Antimicrobials Revenue Market Share by Region (2018-2029)
2.3 Global Bacteriophages Antimicrobials Sales Estimates and Forecasts 2018-2029
2.4 Global Bacteriophages Antimicrobials Sales by Region
2.4.1 Global Bacteriophages Antimicrobials Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bacteriophages Antimicrobials Sales by Region (2018-2023)
2.4.3 Global Bacteriophages Antimicrobials Sales by Region (2024-2029)
2.4.4 Global Bacteriophages Antimicrobials Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bacteriophages Antimicrobials Sales by Manufacturers
3.1.1 Global Bacteriophages Antimicrobials Sales by Manufacturers (2018-2023)
3.1.2 Global Bacteriophages Antimicrobials Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bacteriophages Antimicrobials in 2022
3.2 Global Bacteriophages Antimicrobials Revenue by Manufacturers
3.2.1 Global Bacteriophages Antimicrobials Revenue by Manufacturers (2018-2023)
3.2.2 Global Bacteriophages Antimicrobials Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bacteriophages Antimicrobials Revenue in 2022
3.3 Global Key Players of Bacteriophages Antimicrobials, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bacteriophages Antimicrobials Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bacteriophages Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bacteriophages Antimicrobials, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bacteriophages Antimicrobials, Product Offered and Application
3.8 Global Key Manufacturers of Bacteriophages Antimicrobials, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bacteriophages Antimicrobials Sales by Type
4.1.1 Global Bacteriophages Antimicrobials Historical Sales by Type (2018-2023)
4.1.2 Global Bacteriophages Antimicrobials Forecasted Sales by Type (2024-2029)
4.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Type (2018-2029)
4.2 Global Bacteriophages Antimicrobials Revenue by Type
4.2.1 Global Bacteriophages Antimicrobials Historical Revenue by Type (2018-2023)
4.2.2 Global Bacteriophages Antimicrobials Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Type (2018-2029)
4.3 Global Bacteriophages Antimicrobials Price by Type
4.3.1 Global Bacteriophages Antimicrobials Price by Type (2018-2023)
4.3.2 Global Bacteriophages Antimicrobials Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bacteriophages Antimicrobials Sales by Application
5.1.1 Global Bacteriophages Antimicrobials Historical Sales by Application (2018-2023)
5.1.2 Global Bacteriophages Antimicrobials Forecasted Sales by Application (2024-2029)
5.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Application (2018-2029)
5.2 Global Bacteriophages Antimicrobials Revenue by Application
5.2.1 Global Bacteriophages Antimicrobials Historical Revenue by Application (2018-2023)
5.2.2 Global Bacteriophages Antimicrobials Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Application (2018-2029)
5.3 Global Bacteriophages Antimicrobials Price by Application
5.3.1 Global Bacteriophages Antimicrobials Price by Application (2018-2023)
5.3.2 Global Bacteriophages Antimicrobials Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bacteriophages Antimicrobials Market Size by Type
6.1.1 US & Canada Bacteriophages Antimicrobials Sales by Type (2018-2029)
6.1.2 US & Canada Bacteriophages Antimicrobials Revenue by Type (2018-2029)
6.2 US & Canada Bacteriophages Antimicrobials Market Size by Application
6.2.1 US & Canada Bacteriophages Antimicrobials Sales by Application (2018-2029)
6.2.2 US & Canada Bacteriophages Antimicrobials Revenue by Application (2018-2029)
6.3 US & Canada Bacteriophages Antimicrobials Market Size by Country
6.3.1 US & Canada Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bacteriophages Antimicrobials Sales by Country (2018-2029)
6.3.3 US & Canada Bacteriophages Antimicrobials Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bacteriophages Antimicrobials Market Size by Type
7.1.1 Europe Bacteriophages Antimicrobials Sales by Type (2018-2029)
7.1.2 Europe Bacteriophages Antimicrobials Revenue by Type (2018-2029)
7.2 Europe Bacteriophages Antimicrobials Market Size by Application
7.2.1 Europe Bacteriophages Antimicrobials Sales by Application (2018-2029)
7.2.2 Europe Bacteriophages Antimicrobials Revenue by Application (2018-2029)
7.3 Europe Bacteriophages Antimicrobials Market Size by Country
7.3.1 Europe Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bacteriophages Antimicrobials Sales by Country (2018-2029)
7.3.3 Europe Bacteriophages Antimicrobials Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bacteriophages Antimicrobials Market Size
8.1.1 China Bacteriophages Antimicrobials Sales (2018-2029)
8.1.2 China Bacteriophages Antimicrobials Revenue (2018-2029)
8.2 China Bacteriophages Antimicrobials Market Size by Application
8.2.1 China Bacteriophages Antimicrobials Sales by Application (2018-2029)
8.2.2 China Bacteriophages Antimicrobials Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bacteriophages Antimicrobials Market Size by Type
9.1.1 Asia Bacteriophages Antimicrobials Sales by Type (2018-2029)
9.1.2 Asia Bacteriophages Antimicrobials Revenue by Type (2018-2029)
9.2 Asia Bacteriophages Antimicrobials Market Size by Application
9.2.1 Asia Bacteriophages Antimicrobials Sales by Application (2018-2029)
9.2.2 Asia Bacteriophages Antimicrobials Revenue by Application (2018-2029)
9.3 Asia Bacteriophages Antimicrobials Sales by Region
9.3.1 Asia Bacteriophages Antimicrobials Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bacteriophages Antimicrobials Revenue by Region (2018-2029)
9.3.3 Asia Bacteriophages Antimicrobials Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Market Size by Type
10.1.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Market Size by Application
10.2.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Country
10.3.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Vésale Bioscience
11.1.1 Vésale Bioscience Company Information
11.1.2 Vésale Bioscience Overview
11.1.3 Vésale Bioscience Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Vésale Bioscience Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Vésale Bioscience Recent Developments
11.2 Adaptive Phage Therapeutics
11.2.1 Adaptive Phage Therapeutics Company Information
11.2.2 Adaptive Phage Therapeutics Overview
11.2.3 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Adaptive Phage Therapeutics Recent Developments
11.3 Proteon Pharmaceuticals
11.3.1 Proteon Pharmaceuticals Company Information
11.3.2 Proteon Pharmaceuticals Overview
11.3.3 Proteon Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Proteon Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Proteon Pharmaceuticals Recent Developments
11.4 PHIOGEN
11.4.1 PHIOGEN Company Information
11.4.2 PHIOGEN Overview
11.4.3 PHIOGEN Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 PHIOGEN Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PHIOGEN Recent Developments
11.5 Phageguard
11.5.1 Phageguard Company Information
11.5.2 Phageguard Overview
11.5.3 Phageguard Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Phageguard Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Phageguard Recent Developments
11.6 Armata Pharmaceuticals
11.6.1 Armata Pharmaceuticals Company Information
11.6.2 Armata Pharmaceuticals Overview
11.6.3 Armata Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Armata Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Armata Pharmaceuticals Recent Developments
11.7 ACD Pharmaceuticals
11.7.1 ACD Pharmaceuticals Company Information
11.7.2 ACD Pharmaceuticals Overview
11.7.3 ACD Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 ACD Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ACD Pharmaceuticals Recent Developments
11.8 SyntBioLab
11.8.1 SyntBioLab Company Information
11.8.2 SyntBioLab Overview
11.8.3 SyntBioLab Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 SyntBioLab Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SyntBioLab Recent Developments
11.9 Antibody Design Labs
11.9.1 Antibody Design Labs Company Information
11.9.2 Antibody Design Labs Overview
11.9.3 Antibody Design Labs Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Antibody Design Labs Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Antibody Design Labs Recent Developments
11.10 APS Biocontrol
11.10.1 APS Biocontrol Company Information
11.10.2 APS Biocontrol Overview
11.10.3 APS Biocontrol Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 APS Biocontrol Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 APS Biocontrol Recent Developments
11.11 BiomX
11.11.1 BiomX Company Information
11.11.2 BiomX Overview
11.11.3 BiomX Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 BiomX Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BiomX Recent Developments
11.12 EcoPhage
11.12.1 EcoPhage Company Information
11.12.2 EcoPhage Overview
11.12.3 EcoPhage Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 EcoPhage Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EcoPhage Recent Developments
11.13 Ecolyse
11.13.1 Ecolyse Company Information
11.13.2 Ecolyse Overview
11.13.3 Ecolyse Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Ecolyse Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ecolyse Recent Developments
11.14 Fixed Phage
11.14.1 Fixed Phage Company Information
11.14.2 Fixed Phage Overview
11.14.3 Fixed Phage Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Fixed Phage Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Fixed Phage Recent Developments
11.15 Intralytix
11.15.1 Intralytix Company Information
11.15.2 Intralytix Overview
11.15.3 Intralytix Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Intralytix Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Intralytix Recent Developments
11.16 Locus Biosciences
11.16.1 Locus Biosciences Company Information
11.16.2 Locus Biosciences Overview
11.16.3 Locus Biosciences Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Locus Biosciences Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Locus Biosciences Recent Developments
11.17 Micreos
11.17.1 Micreos Company Information
11.17.2 Micreos Overview
11.17.3 Micreos Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Micreos Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Micreos Recent Developments
11.18 OmniLytics
11.18.1 OmniLytics Company Information
11.18.2 OmniLytics Overview
11.18.3 OmniLytics Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 OmniLytics Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 OmniLytics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bacteriophages Antimicrobials Industry Chain Analysis
12.2 Bacteriophages Antimicrobials Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bacteriophages Antimicrobials Production Mode & Process
12.4 Bacteriophages Antimicrobials Sales and Marketing
12.4.1 Bacteriophages Antimicrobials Sales Channels
12.4.2 Bacteriophages Antimicrobials Distributors
12.5 Bacteriophages Antimicrobials Customers
13 Market Dynamics
13.1 Bacteriophages Antimicrobials Industry Trends
13.2 Bacteriophages Antimicrobials Market Drivers
13.3 Bacteriophages Antimicrobials Market Challenges
13.4 Bacteriophages Antimicrobials Market Restraints
14 Key Findings in The Global Bacteriophages Antimicrobials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Bacteriophages, often simply called phages, are viruses that infect and replicate within bacteria. Bacteriophages are natural enemies of bacteria, and they can be harnessed for their antimicrobial properties. Bacteriophages are specific to bacteria, and each type of phage typically infects only a particular strain or species of bacteria.

Bacteriophages infect bacteria by attaching to specific receptors on the bacterial cell surface. Once attached, the phage injects its genetic material into the bacterium, taking over the bacterial machinery to replicate and produce new phage particles. As the new phage particles are produced, they eventually cause the bacterial cell to burst or lyse, releasing the newly formed phages. This process results in the destruction of the bacterial cell.

One of the key advantages of bacteriophages is their specificity. Each type of phage has a narrow host range, meaning it can only infect certain types or strains of bacteria. This specificity allows for targeted antimicrobial action without affecting non-bacterial cells, including human cells.
Bacteriophages have been explored as potential therapeutic agents against bacterial infections. This approach, known as phage therapy, involves using specific phages to target and kill pathogenic bacteria. Phage therapy has been investigated as an alternative or complementary treatment to antibiotics. Bacteriophages are used in the food industry to control bacterial contamination. They can be applied to foods to target and reduce the levels of harmful bacteria, improving food safety.

Global Bacteriophages Antimicrobials market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Bacteriophages Antimicrobials industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029.

Globally, Bacteriophages Antimicrobials key manufacturers include Vésale Bioscience, Adaptive Phage Therapeutics, Proteon Pharmaceuticals, PHIOGEN, Phageguard, Armata Pharmaceuticals, ACD Pharmaceuticals, SyntBioLab and Antibody Design Labs, etc. Vésale Bioscience, Adaptive Phage Therapeutics, Proteon Pharmaceuticals are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Bacteriophages Antimicrobials were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Bacteriophages Antimicrobials market and estimated to attract more attentions from industry insiders and investors.

Bacteriophages Antimicrobials can be divided into for Human, for Animals and for Plants,, etc. for Human is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Bacteriophages Antimicrobials is widely used in various fields, such as Medical, Food Industry, Agriculture and Others, etc. Medical provides greatest supports to the Bacteriophages Antimicrobials industry development. In 2022, global % sales of Bacteriophages Antimicrobials went into Medical filed and the proportion will reach to % in 2029.

Report Covers:
This report presents an overview of global Bacteriophages Antimicrobials market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bacteriophages Antimicrobials market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Proteon Pharmaceuticals
PHIOGEN
Phageguard
Armata Pharmaceuticals
ACD Pharmaceuticals
SyntBioLab
Antibody Design Labs
APS Biocontrol
BiomX
EcoPhage
Ecolyse
Fixed Phage
Intralytix
Locus Biosciences
Micreos
OmniLytics
Segment by Type
by End Users
for Human
for Animals
for Plants
by Genome
DsDNA Bacteriophage
SsDNA Bacteriophage
DsRNA Bacteriophage
SsRNA Bacteriophage
Segment by Application
Medical
Food Industry
Agriculture
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Bacteriophages Antimicrobials plant distribution, commercial date of Bacteriophages Antimicrobials, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, Bacteriophages Antimicrobials introduction, etc. Bacteriophages Antimicrobials Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of Bacteriophages Antimicrobials
Chapter 15: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Bacteriophages Antimicrobials Product Introduction
1.2 Market by Type
1.2.1 Global Bacteriophages Antimicrobials Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 for Human
1.2.3 for Animals
1.2.4 for Plants
1.3 Market by Application
1.3.1 Global Bacteriophages Antimicrobials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Food Industry
1.3.4 Agriculture
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bacteriophages Antimicrobials Sales Estimates and Forecasts 2018-2029
2.2 Global Bacteriophages Antimicrobials Revenue by Region
2.2.1 Global Bacteriophages Antimicrobials Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Bacteriophages Antimicrobials Revenue by Region (2018-2023)
2.2.3 Global Bacteriophages Antimicrobials Revenue by Region (2024-2029)
2.2.4 Global Bacteriophages Antimicrobials Revenue Market Share by Region (2018-2029)
2.3 Global Bacteriophages Antimicrobials Sales Estimates and Forecasts 2018-2029
2.4 Global Bacteriophages Antimicrobials Sales by Region
2.4.1 Global Bacteriophages Antimicrobials Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Bacteriophages Antimicrobials Sales by Region (2018-2023)
2.4.3 Global Bacteriophages Antimicrobials Sales by Region (2024-2029)
2.4.4 Global Bacteriophages Antimicrobials Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Bacteriophages Antimicrobials Sales by Manufacturers
3.1.1 Global Bacteriophages Antimicrobials Sales by Manufacturers (2018-2023)
3.1.2 Global Bacteriophages Antimicrobials Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bacteriophages Antimicrobials in 2022
3.2 Global Bacteriophages Antimicrobials Revenue by Manufacturers
3.2.1 Global Bacteriophages Antimicrobials Revenue by Manufacturers (2018-2023)
3.2.2 Global Bacteriophages Antimicrobials Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Bacteriophages Antimicrobials Revenue in 2022
3.3 Global Key Players of Bacteriophages Antimicrobials, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Bacteriophages Antimicrobials Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bacteriophages Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bacteriophages Antimicrobials, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bacteriophages Antimicrobials, Product Offered and Application
3.8 Global Key Manufacturers of Bacteriophages Antimicrobials, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bacteriophages Antimicrobials Sales by Type
4.1.1 Global Bacteriophages Antimicrobials Historical Sales by Type (2018-2023)
4.1.2 Global Bacteriophages Antimicrobials Forecasted Sales by Type (2024-2029)
4.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Type (2018-2029)
4.2 Global Bacteriophages Antimicrobials Revenue by Type
4.2.1 Global Bacteriophages Antimicrobials Historical Revenue by Type (2018-2023)
4.2.2 Global Bacteriophages Antimicrobials Forecasted Revenue by Type (2024-2029)
4.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Type (2018-2029)
4.3 Global Bacteriophages Antimicrobials Price by Type
4.3.1 Global Bacteriophages Antimicrobials Price by Type (2018-2023)
4.3.2 Global Bacteriophages Antimicrobials Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Bacteriophages Antimicrobials Sales by Application
5.1.1 Global Bacteriophages Antimicrobials Historical Sales by Application (2018-2023)
5.1.2 Global Bacteriophages Antimicrobials Forecasted Sales by Application (2024-2029)
5.1.3 Global Bacteriophages Antimicrobials Sales Market Share by Application (2018-2029)
5.2 Global Bacteriophages Antimicrobials Revenue by Application
5.2.1 Global Bacteriophages Antimicrobials Historical Revenue by Application (2018-2023)
5.2.2 Global Bacteriophages Antimicrobials Forecasted Revenue by Application (2024-2029)
5.2.3 Global Bacteriophages Antimicrobials Revenue Market Share by Application (2018-2029)
5.3 Global Bacteriophages Antimicrobials Price by Application
5.3.1 Global Bacteriophages Antimicrobials Price by Application (2018-2023)
5.3.2 Global Bacteriophages Antimicrobials Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Bacteriophages Antimicrobials Market Size by Type
6.1.1 US & Canada Bacteriophages Antimicrobials Sales by Type (2018-2029)
6.1.2 US & Canada Bacteriophages Antimicrobials Revenue by Type (2018-2029)
6.2 US & Canada Bacteriophages Antimicrobials Market Size by Application
6.2.1 US & Canada Bacteriophages Antimicrobials Sales by Application (2018-2029)
6.2.2 US & Canada Bacteriophages Antimicrobials Revenue by Application (2018-2029)
6.3 US & Canada Bacteriophages Antimicrobials Market Size by Country
6.3.1 US & Canada Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Bacteriophages Antimicrobials Sales by Country (2018-2029)
6.3.3 US & Canada Bacteriophages Antimicrobials Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Bacteriophages Antimicrobials Market Size by Type
7.1.1 Europe Bacteriophages Antimicrobials Sales by Type (2018-2029)
7.1.2 Europe Bacteriophages Antimicrobials Revenue by Type (2018-2029)
7.2 Europe Bacteriophages Antimicrobials Market Size by Application
7.2.1 Europe Bacteriophages Antimicrobials Sales by Application (2018-2029)
7.2.2 Europe Bacteriophages Antimicrobials Revenue by Application (2018-2029)
7.3 Europe Bacteriophages Antimicrobials Market Size by Country
7.3.1 Europe Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Bacteriophages Antimicrobials Sales by Country (2018-2029)
7.3.3 Europe Bacteriophages Antimicrobials Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Bacteriophages Antimicrobials Market Size
8.1.1 China Bacteriophages Antimicrobials Sales (2018-2029)
8.1.2 China Bacteriophages Antimicrobials Revenue (2018-2029)
8.2 China Bacteriophages Antimicrobials Market Size by Application
8.2.1 China Bacteriophages Antimicrobials Sales by Application (2018-2029)
8.2.2 China Bacteriophages Antimicrobials Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bacteriophages Antimicrobials Market Size by Type
9.1.1 Asia Bacteriophages Antimicrobials Sales by Type (2018-2029)
9.1.2 Asia Bacteriophages Antimicrobials Revenue by Type (2018-2029)
9.2 Asia Bacteriophages Antimicrobials Market Size by Application
9.2.1 Asia Bacteriophages Antimicrobials Sales by Application (2018-2029)
9.2.2 Asia Bacteriophages Antimicrobials Revenue by Application (2018-2029)
9.3 Asia Bacteriophages Antimicrobials Sales by Region
9.3.1 Asia Bacteriophages Antimicrobials Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Bacteriophages Antimicrobials Revenue by Region (2018-2029)
9.3.3 Asia Bacteriophages Antimicrobials Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Market Size by Type
10.1.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Market Size by Application
10.2.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Country
10.3.1 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Bacteriophages Antimicrobials Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Bacteriophages Antimicrobials Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Vésale Bioscience
11.1.1 Vésale Bioscience Company Information
11.1.2 Vésale Bioscience Overview
11.1.3 Vésale Bioscience Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Vésale Bioscience Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Vésale Bioscience Recent Developments
11.2 Adaptive Phage Therapeutics
11.2.1 Adaptive Phage Therapeutics Company Information
11.2.2 Adaptive Phage Therapeutics Overview
11.2.3 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Adaptive Phage Therapeutics Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Adaptive Phage Therapeutics Recent Developments
11.3 Proteon Pharmaceuticals
11.3.1 Proteon Pharmaceuticals Company Information
11.3.2 Proteon Pharmaceuticals Overview
11.3.3 Proteon Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Proteon Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Proteon Pharmaceuticals Recent Developments
11.4 PHIOGEN
11.4.1 PHIOGEN Company Information
11.4.2 PHIOGEN Overview
11.4.3 PHIOGEN Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 PHIOGEN Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PHIOGEN Recent Developments
11.5 Phageguard
11.5.1 Phageguard Company Information
11.5.2 Phageguard Overview
11.5.3 Phageguard Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Phageguard Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Phageguard Recent Developments
11.6 Armata Pharmaceuticals
11.6.1 Armata Pharmaceuticals Company Information
11.6.2 Armata Pharmaceuticals Overview
11.6.3 Armata Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Armata Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Armata Pharmaceuticals Recent Developments
11.7 ACD Pharmaceuticals
11.7.1 ACD Pharmaceuticals Company Information
11.7.2 ACD Pharmaceuticals Overview
11.7.3 ACD Pharmaceuticals Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 ACD Pharmaceuticals Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ACD Pharmaceuticals Recent Developments
11.8 SyntBioLab
11.8.1 SyntBioLab Company Information
11.8.2 SyntBioLab Overview
11.8.3 SyntBioLab Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 SyntBioLab Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SyntBioLab Recent Developments
11.9 Antibody Design Labs
11.9.1 Antibody Design Labs Company Information
11.9.2 Antibody Design Labs Overview
11.9.3 Antibody Design Labs Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Antibody Design Labs Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Antibody Design Labs Recent Developments
11.10 APS Biocontrol
11.10.1 APS Biocontrol Company Information
11.10.2 APS Biocontrol Overview
11.10.3 APS Biocontrol Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 APS Biocontrol Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 APS Biocontrol Recent Developments
11.11 BiomX
11.11.1 BiomX Company Information
11.11.2 BiomX Overview
11.11.3 BiomX Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 BiomX Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BiomX Recent Developments
11.12 EcoPhage
11.12.1 EcoPhage Company Information
11.12.2 EcoPhage Overview
11.12.3 EcoPhage Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 EcoPhage Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EcoPhage Recent Developments
11.13 Ecolyse
11.13.1 Ecolyse Company Information
11.13.2 Ecolyse Overview
11.13.3 Ecolyse Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Ecolyse Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ecolyse Recent Developments
11.14 Fixed Phage
11.14.1 Fixed Phage Company Information
11.14.2 Fixed Phage Overview
11.14.3 Fixed Phage Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Fixed Phage Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Fixed Phage Recent Developments
11.15 Intralytix
11.15.1 Intralytix Company Information
11.15.2 Intralytix Overview
11.15.3 Intralytix Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Intralytix Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Intralytix Recent Developments
11.16 Locus Biosciences
11.16.1 Locus Biosciences Company Information
11.16.2 Locus Biosciences Overview
11.16.3 Locus Biosciences Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Locus Biosciences Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Locus Biosciences Recent Developments
11.17 Micreos
11.17.1 Micreos Company Information
11.17.2 Micreos Overview
11.17.3 Micreos Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Micreos Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Micreos Recent Developments
11.18 OmniLytics
11.18.1 OmniLytics Company Information
11.18.2 OmniLytics Overview
11.18.3 OmniLytics Bacteriophages Antimicrobials Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 OmniLytics Bacteriophages Antimicrobials Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 OmniLytics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bacteriophages Antimicrobials Industry Chain Analysis
12.2 Bacteriophages Antimicrobials Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bacteriophages Antimicrobials Production Mode & Process
12.4 Bacteriophages Antimicrobials Sales and Marketing
12.4.1 Bacteriophages Antimicrobials Sales Channels
12.4.2 Bacteriophages Antimicrobials Distributors
12.5 Bacteriophages Antimicrobials Customers
13 Market Dynamics
13.1 Bacteriophages Antimicrobials Industry Trends
13.2 Bacteriophages Antimicrobials Market Drivers
13.3 Bacteriophages Antimicrobials Market Challenges
13.4 Bacteriophages Antimicrobials Market Restraints
14 Key Findings in The Global Bacteriophages Antimicrobials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る